Photosensitizer loaded HSA nanoparticles II: in vitro investigations.

The photosensitizing efficiency of human serum albumin (HSA) nanoparticles loaded with the photosensitizers meta-tetra(hydroxy-phenyl)-chlorin (mTHPC) and meta-tetra(hydroxy-phenyl)-porphyrin (mTHPP) was investigated in vitro. The endocytotic intracellular uptake, and the time dependent drug release caused by nanoparticle decomposition of the PS loaded HSA nanoparticles were studied on Jurkat cells in suspension. The photoxicity as well as the intracellular singlet oxygen ((1)O(2)) generation were investigated in dependence on the incubation time. The obtained results show that HSA nanoparticles are promising carriers for the clinical used mTHPC (Foscan). After release the ((1)O(2)) generation as well as the phototoxicity are more efficient compared with mTHPC applied without the HSA nanoparticles.

[1]  Christopher S. Foote,et al.  Mechanisms of Photosensitized Oxidation , 1968 .

[2]  I. Tan,et al.  Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. , 2003, Archives of otolaryngology--head & neck surgery.

[3]  B. Röder,et al.  Fullerene-pyropheophorbide a complexes as sensitizer for photodynamic therapy: uptake and photo-induced cytotoxicity on Jurkat cells. , 2005, Journal of photochemistry and photobiology. B, Biology.

[4]  L. Bezdetnaya,et al.  Modality of Cell Death Induced by Foscan®-Based Photodynamic Treatment in Human Colon Adenocarcinoma Cell Line HT29 , 2004, Biochemistry (Moscow).

[5]  B. Röder,et al.  Time-resolved detection of singlet oxygen luminescence in red-cell ghost suspensions: concerning a signal component that can be attributed to 1O2 luminescence from the inside of a native membrane. , 1997, Journal of photochemistry and photobiology. B, Biology.

[6]  I. Tan,et al.  mTHPC‐mediated photodynamic therapy for early oral squamous cell carcinoma , 2004, International journal of cancer.

[7]  François Guillemin,et al.  Investigation of Foscan interactions with plasma proteins. , 2005, Biochimica et biophysica acta.

[8]  Q. Peng,et al.  Photodynamic Therapy , 1988, Methods in Molecular Biology.

[9]  Nancy L Oleinick,et al.  The role of apoptosis in response to photodynamic therapy: what, where, why, and how , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[10]  Arno Wiehe,et al.  Influence of substitutions on asymmetric dihydroxychlorins with regard to intracellular uptake, subcellular localization and photosensitization of Jurkat cells. , 2005, Journal of photochemistry and photobiology. B, Biology.

[11]  S. Hackbarth,et al.  Photophysical evaluation of mTHPC-loaded HSA nanoparticles as novel PDT delivery systems. , 2010, Journal of photochemistry and photobiology. B, Biology.

[12]  B. Röder,et al.  Alkyl-substituted magnesium phthalocyanine: phototoxicity after excitation of higher electronic states in cells in vitro , 2002 .

[13]  C. Foote.  Mechanisms of photosensitized oxidation. There are several different types of photosensitized oxidation which may be important in biological systems. , 1968, Science.

[14]  Comparative study of the photosensitization of Jurkat cells in vitro by pheophorbide-a and a pheophorbide-a diaminobutane poly-propylene-imine dendrimer complex , 2003 .

[15]  H von Briesen,et al.  Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  V. Diehl,et al.  Lymphocyte predominant Hodgkin's disease: pathology and clinical implication. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  S. Hackbarth,et al.  A new benchmark for time-resolved detection of singlet oxygen luminescence – revealing the evolution of lifetime in living cells with low dose illumination , 2009 .

[18]  H. Maeda,et al.  Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[19]  M. Michaelis,et al.  Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. , 2007, International journal of pharmaceutics.

[20]  Matthias Wacker,et al.  Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties. , 2010, International journal of pharmaceutics.

[21]  V. Vogel,et al.  Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation. , 2008, International journal of pharmaceutics.

[22]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[23]  K. Kisich,et al.  The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. , 2005, American journal of respiratory and critical care medicine.

[24]  M C Berenbaum,et al.  Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. , 1989, The Biochemical journal.

[25]  C. Lillo,et al.  Albumin endocytosis via megalin in astrocytes is caveola‐ and Dab‐1 dependent and is required for the synthesis of the neurotrophic factor oleic acid , 2009, Journal of neurochemistry.

[26]  I. Pastan,et al.  Endocytosis and exocytosis: current concepts of vesicle traffic in animal cells. , 1984, International review of cytology.

[27]  A. Velasco,et al.  Transcytosis of Albumin in Astrocytes Activates the Sterol Regulatory Element-binding Protein-1, Which Promotes the Synthesis of the Neurotrophic Factor Oleic Acid* , 2002, The Journal of Biological Chemistry.

[28]  J Moan,et al.  Evaluation of a new photosensitizer, meso‐tetra‐hydroxyphenyl‐chlorin, for use in photodynamic therapy: A comparison of its photobiological properties with those of two other photosensitizers , 1994, International journal of cancer.

[29]  S. Hackbarth,et al.  Novel photosensitizer-protein nanoparticles for photodynamic therapy: photophysical characterization and in vitro investigations. , 2009, Journal of photochemistry and photobiology. B, Biology.

[30]  D. Kessel,et al.  Mitochondrial photodamage and PDT-induced apoptosis. , 1998, Journal of photochemistry and photobiology. B, Biology.

[31]  Matthias Helmreich,et al.  Trap formation and energy transfer in pheophorbide a-DAB-dendrimers and pyropheophorbide a-fullerene C60 hexaadduct molecular systems , 2006, SPIE Photonics Europe.

[32]  N. Mak,et al.  Photodynamic Effects of mTHPC on Human Colon Adenocarcinoma Cells: Photocytotoxicity, Subcellular Localization and Apoptosis¶ , 2002, Photochemistry and photobiology.

[33]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[34]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.